JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2017, 66(4):154-159 | DOI: 10.36290/csf.2017.023

Possibilities of using sodium hyaluronate in pharmaceutical and medical fields

Veronika Pechová, Jan Gajdziok*
Ústav technologie léků, Farmaceutická fakulta, Veterinární a farmaceutická univerzita, Brno

Sodium hyaluronate represents a contemporary biomaterial with broad use in different pharmaceutical and medical fields. It is a physiological glycosaminoglycan, which occurs primarily in the extracellular matrix, synovial fluid, cartilage, epidermis and vitreous body. It plays a critical role as a signalling molecule in immunological processes, cell motility and wound healing, and it possesses antioxidant activity. It is used in many fields of medicine if supplementation of hyaluronan is needed or in the cases of preventive and therapeutic interventions. Thanks to its moisturizing, regenerative and protective effects it is used in cosmetics as well.

Keywords: sodium hyaluronate; hyaluronic acid; hyaluronan; derivatives of sodium hyaluronate; dosage forms; medicinal use

Received: July 12, 2017; Accepted: July 27, 2017; Published: April 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pechová V, Gajdziok J. Possibilities of using sodium hyaluronate in pharmaceutical and medical fields. Čes. slov. farm. 2017;66(4):154-159. doi: 10.36290/csf.2017.023.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ministerstvo zdravotnictví ČR. Český lékopis 2009. 1. vydání. Praha: Grada Publishing 2009.
    2. Balazs E. A., Laurent T. C., Jeanloz R. W. Nomenclature of hyaluronic acid. Biochem. J. 1986; 235, 903. Go to original source... Go to PubMed...
    3. Schiller J., Volpi N., Hrabárová E., Šoltés L. Hyaluronic acid: A natural biopolymer. In: Kalia S., Avérous L. (eds.) Biopolymers: Biomedical and environmental applications. Hoboken: John Wiley and Sons 2011. Go to original source...
    4. Sosnik A., das Neves J., Sarmento B. Mucoadhesive polymers in the design of nanodrug delivery systems for administration by non-parenteral routes: A review. Prog. Polym. Sci. 2014; 39, 2030-2075. Go to original source...
    5. Volpi N., Schiller J., Stern R., Soltés L. Role, metabolism, chemical modifications and applications of hyaluronan. Curr. Med. Chem. 2009; 16, 1718-1745. Go to original source... Go to PubMed...
    6. Slíva J., Minárik J. Hyaluronát - nejen pasivní pozorovatel, nýbrž aktivní modulátor imunitních reakcí. New EU Magazine of Medicine. 2009; 1-2, 75-79.
    7. Fraser J. R., Laurent T. C., Laurent U. B. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 1997; 242, 27-33. Go to original source... Go to PubMed...
    8. Laurent T. C., Laurent U. B. G., Fraser J. R. E. The structure and function of hyaluronan: An overview. Immunol. Cell Biol. 1996; 74, A1-A7. Go to original source... Go to PubMed...
    9. Hašová M., Crhák T., Safránková B., Dvořáková J., Muthný T., Velebný V., Kubala L. Hyaluronan minimizes effects of UV irradiation on human keratinocytes. Arch. Dermatol. Res. 2011; 303, 277-284. Go to original source... Go to PubMed...
    10. Meyer K., Palmer J. W. The polysaccharide of the vitreous humor. J. Biol. Chem. 1934; 107, 629-634. Go to original source...
    11. Necas J., Bartosikova L, Brauner P., Kolar J. Hyaluronic acid (hyaluronan): a review. Vet. Med. 2008; 53, 397-411. Go to original source...
    12. Long F. D., Adams R. G., DeVore D. P. Preparation of hyaluronic acid from eggshell membrane. US Patent No. 6946551; 2005.
    13. Contipro. Hyaluronic acid. https://www.contipro.com/images/ProductLists/Hyaluronic-Acid_Contipro.pdf (29. 6. 2017).
    14. Schiraldi Ch., La Gatta A., de Rosa M. Biotechnological Production and Application of Hyaluronan. In: Elnashar M. eds. Biopolymers. Rijeka: Intech 2010. Go to original source...
    15. Larsen N. E., Balazs E. A. Drug delivery systems using hyaluronan and its derivatives. Adv. Drug Delivery Rev. 1991; 7, 279-293. Go to original source...
    16. Šedová P., Buffa R., Kettou S., Huerta-Angeles G., Hermannová M., Leierová V., Šmejkalová D., Moravcová M., Velebný V. Preparation of hyaluronan polyaldehyde-a precursor of biopolymer conjugates. Carbohydr. Res. 2013; 371, 8-15. Go to original source... Go to PubMed...
    17. Uhart M., Pirot F., Boillon A., Senaux E., Tall L., Diouf E., Burillon C., Padois K., Falson F., Leboucher G., Pivot C. Assessment of sodium hyaluronate gel as vehicle for intracameral delivery of cefuroxime in endophthalmitis prophylaxis. Int. J. Pharm. 2010; 398, 14-20. Go to original source... Go to PubMed...
    18. Kuchynka P. Oční lékařství. 2., přepracované a doplněné vydání. Praha: Grada Publishing 2016.
    19. Arshinoff S. A. Dispersive-cohesive viscoelastic soft shell technique. J. Cataract. Refract. Surg. 1999; 25, 167-173. Go to original source... Go to PubMed...
    20. Nepp J., Schauersberger J., Schild G., Jandrasits K., Haslinger-Akramian J., Derbolav A., Wedrich A. The clinical use of viscoelastic artificial tears and sodium chloride in dry-eye syndrome. Biomaterials. 2001; 22, 3305-3310. Go to original source... Go to PubMed...
    21. Varcholová D. Současné možnosti v substituční terapii syndromu suchého oka. Remedia 2006; 5, 2006, 503-508.
    22. Odehnal M., Ferrová K., Malec J. Léčba suchého oka - Poruchy slzných žláz, slzného filmu a využití umělých slz v praxi. Praktické lékárenství 2010; 6, 149-152.
    23. Messmer E. M. Konservierungsmittel in der Ophthalmologie. Ophthalmologie 2012; 109, 1064-1070. Go to original source... Go to PubMed...
    24. Ursapharm. COMOD®-systém. http://ursapharm.cz/cz/vyroba-systemy/comod-system/ (29. 6. 2017).
    25. Théa. ABAK Pure technology in a bottle. http://www.laboratoires-thea.com/medias/abak_brochure_eng.pdf (29. 6. 2017).
    26. Engström-Laurent A. Hyaluronan in joint disease (Minisymposium: Hyaluronan). J. Intern. Med. 1997; 242, 57-60. Go to original source... Go to PubMed...
    27. Akmal M., Singh A., Anand A., Kesani A., Aslam N., Goodship A., Bentley G. The effects of hyaluronic acid on articular chondrocytes. J. Bone Jt. Surg. Br. Vol. 2005; 87, 1143-1149. Go to original source... Go to PubMed...
    28. Trč T. Současný stav viskosuplementace v léčbě osteoartrózy. Farmakoterapie 2012; 8, 608-611.
    29. Butler J., Rydell N. W., Balazs E. A. Hyaluronic acid in synovial fluid. VI. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses. Acta Vet. Scand. 1970; 11, 139-155. Go to original source... Go to PubMed...
    30. Frei R. Viskosuplementace v léčbě osteoartrózy. Farmakoterapie v praxi (ortopedie, revmatologie) 2014; 5, 3-6.
    31. Contipro. Nutrihyl®. http://www.aktivnizvire.cz/hyaluronan-pro-klouby (29. 6. 2017).
    32. Balogh L., Polyak A., Mathe D., Kiraly R., Thuroczy J., Terez M., Janoki G., Ting Y., Bucci L. R., Schauss A. G. Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs. J. Agric. Food Chem. 2008; 56, 10582-10593. Go to original source... Go to PubMed...
    33. Sahbaz A., Aynioglu O., Isik H., Ozmen U., Cengil O., Gun B. D., Gungorduk K. Bromelain: A natural proteolytic for intra-abdominal adhesion prevention. Int. J. Surg. 2015; 14, 7-11. Go to original source... Go to PubMed...
    34. Matěna O. Antiadhezivní prostředky v laparoskopické operativě. Prakt. Gyn. 2013; 17, 237-240.
    35. Křižan V., Pánková S., Hudeček R. Význam hyaluronátu v gynekologii a porodnictví. Prakt. Gyn. 2012; 16, 7-12.
    36. Pánková S., Hudeček R., Račanská E. Peroperační prevence adhezí v gynekologii. Prakt. Gyn. 2009; 13, 70-75.
    37. Huang H., Deng M., Jin H., Dirsch O., Dahmen U. Preventing intra-abdominal adhesions with a sodium hyaluronate carboxymethylcellulose membrane enabled visualization of hepatic microcirculation. Int. J. Surg. 2013; 11, 935-943. Go to original source... Go to PubMed...
    38. Juhlin L. Hyaluronan in skin. J. Intern. Med. 1997; 242, 61-66. Go to original source... Go to PubMed...
    39. Borzacchiello A., Russo L., Malle B. M., Schwach-Abdellaoui K., Ambrosio, L. Hyaluronic acid based hydrogels for regenerative medicine applications. BioMed Research International 2015; 2015, 1-12. Go to original source... Go to PubMed...
    40. Dicker K. T., Gurski L. A., Pradhan-Bhatt S., Witt R. L., Farach-Carson M. C., Jia X. Hyaluronan: A simple polysaccharide with diverse biological functions. Acta Biomater. 2014; 10, 1558-1570. Go to original source... Go to PubMed...
    41. Hyiodine®. Příručka k aplikaci. https://www.hyiodine.cz/images/Brochures/hyodine_%20prirucka_k_aplikaci.pdf (29. 6. 2017).
    42. SÚKL. Databáze léků. http://www.sukl.cz/modules/medication/search.php (29. 6. 2017).
    43. Buchsel P. C. Polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair): a bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions. Expert Opin. Drug Metab. Toxicol. 2008; 4, 1449-1454. Go to original source... Go to PubMed...
    44. Gelclair®. Bioadherent oral rinse gel for effective relief of pain associated with oral mucositis. http://www.gelclair.com/ (29. 6. 2017).
    45. Trud™. A new treatment for ulcerative colitis. http://www.treatwithtrud.com/-EN- (29. 6. 2017).
    46. Bortlík M. Hyaluronát sodný: nová cesta v léčbě ulcerózní kolitidy? Gastroent. Hepatol. 2014; 68, 468-469. Go to original source...
    47. Hysan® Care sprej. Návod k použití. http://www.nosnipece.cz/sites/default/files/PB%20HYSAN%20Pfl%20CZ_SK%2090.1656.pdf (29. 6. 2017).
    48. Rejchrt M., Havlová K., Kříž J. Prevence recidivujících uroinfekcí intravezikální instilací kyseliny hyaluronové a chondroitinsulfátu u pacientů po míšním poranění. Urol. praxi 2015; 16, 43.
    49. Romžová M. Možné příčiny vzniku inkontinence a jejich řešení. Urol. praxi 2014; 15, 221-226.
    50. Papakonstantinou E., Roth M., Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012; 4, 253-258. Go to original source... Go to PubMed...
    51. Trommer H., Wartewig S., Bötcher R., Pöppl A., Hoentsch J., Ozegowski J. H., Neubert R. H. The effects of hyaluronan and its fragments on lipid models exposed to UV irradiation. Int. J. Pharm. 2003; 254, 223-234. Go to original source... Go to PubMed...
    52. Baspeyras M., Rouvrais C., Liégard L., Delalleau A., Letellier S., Bacle I., Courrech L., Murat P., Mengeaud V., Schmitt A. M. Clinical and biometrological efficacy of a hyaluronic acid-based mesotherapy product: A randomised controlled study. Arch. Dermatol. Res. 2013; 305, 673-682. Go to original source... Go to PubMed...
    53. Dick H. B., Schwenn O. Viscoelastics in Ophthalmic Surgery. 1. vydání. Berlín: Springer 2000. Go to original source...
    54. Hyabak®. Preservative-free Sodium Hyaluronate dry eye drops. http://www.thea-pharmaceuticals.co.uk/products/hyabak (29. 6. 2017).
    55. Ursapharm. Hylo® Eye Care. http://ursapharm.cz/cz/produkty/zdravotnicke-prostredky/hylo-eye-care/ (29. 6. 2017).
    56. Drug Reference Encyclopedia. Orthovisc. http://www.theodora.com/drugs/orthovisc_injection_depuy_mitek.html (29. 7. 2016).
    57. Sinovial®. Návod k použití. http://www.ibi.cz/download/Sinovial_navod_k_pouziti.pdf (29. 7. 2016).
    58. Dacom® Pharma. Hyalfit®. https://www.dacom.cz/klouby-a-kosti/0-hyalfit-kolagen-kyselina-hyaluronova-kapsle.html (29. 6. 2017).
    59. Silvita. Hyalgel. http://www.hyalgel.cz/hyalgel/eshop/1-1-Hyalgel (29. 6. 2017).

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.